Kineret: payments to doctors
Payments that named Kineret as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $479K
- Providers
- 3,152
- Transactions
- 10,257
- Average per transaction
- $47
The per-transaction average — $47 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,152 providers the average total is $152, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Swedish Orphan Biovitrum AB | $196,448 | 41.0% |
| SOBI, Inc | $179,266 | 37.4% |
| Sobi, Inc | $103,019 | 21.5% |